Brazilian Reality of Hepatocellular Carcinoma

Trial Identifier: D133HR00024
Sponsor: AstraZeneca
Collaborator:
Hospital Israelita Albert Einstein
Start Date: April 2024
Primary Completion Date: November 2024
Study Completion Date: November 2024
Condition: Liver Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Brazil Barretos, Brazil
Brazil Belo Horizonte, Brazil
Brazil Curitiba, Brazil
Brazil Natal, Brazil
Brazil Porto Alegre, Brazil
Brazil Recife, Brazil
Brazil Rio de Janeiro, Brazil
Brazil Salvador, Brazil
Brazil Sao Bernardo do Campo, Brazil
Brazil Vitoria, Brazil